Save your place

Sign in to WhoBought

Please try again later.

Mirum Pharmaceuticals, Inc. (MIRM) institutional ownership

Latest close $114.20 Jul 27, 2026
Market cap$2.6B 52-week range SectorHealthcare
Funds holding · Q1 2026
296
reported MIRM position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
174 buyers · 122 sellers

Mirum Pharmaceuticals, Inc. (MIRM) price and institutional activity

Dates

Q1 2026

$0 bought by 174 investors
VanguardFMR LLC +172 more
$0 sold by 122 investors
D. E. Shaw & Co., Inc.Eventide Asset Management, LLC +120 more
Bought Sold Totals per quarter; hover a bar for the names.

Mirum Pharmaceuticals, Inc. (MIRM) institutional activity · 296

Investor Type Est. change Change Δ Own Date
Vanguard · Added
Change +1.6M Date Q1 2026
Vanguard Added· Q1 2026 +1.6M Q1 2026
FMR LLC · Added
Change +1.3M Δ Own +204.0% Date Q1 2026
FMR LLC Added· Q1 2026 +1.3M +204.0% Q1 2026
Tcg Crossover Management, LLC · Added
Change +1.0M Date Q1 2026
Tcg Crossover Management, LLC Added· Q1 2026 +1.0M Q1 2026
Frazier Life Sciences Management, L.P. · Added
Change +885K Date Q1 2026
Frazier Life Sciences Management, L.P. Added· Q1 2026 +885K Q1 2026
Janus Henderson Group PLC · Added
Change +881K Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +881K Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −781K Δ Own −82.3% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −781K −82.3% Q1 2026
Capital World Investors · New
Change +724K Date Q1 2026
Capital World Investors New· Q1 2026 +724K Q1 2026
Eventide Asset Management, LLC · Reduced
Change −685K Date Q1 2026
Eventide Asset Management, LLC Reduced· Q1 2026 −685K Q1 2026
Paradigm Biocapital Advisors LP · New
Change +625K Date Q1 2026
Paradigm Biocapital Advisors LP New· Q1 2026 +625K Q1 2026
Polar Capital Holdings PLC · Reduced
Change −510K Date Q1 2026
Polar Capital Holdings PLC Reduced· Q1 2026 −510K Q1 2026
Baker Bros. Advisors LP · New
Change +446K Date Q1 2026
Baker Bros. Advisors LP New· Q1 2026 +446K Q1 2026
Two Sigma Investments, LP · Added
Change +386K Δ Own +99.4% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +386K +99.4% Q1 2026
Octagon Capital Advisors LP · New
Change +339K Date Q1 2026
Octagon Capital Advisors LP New· Q1 2026 +339K Q1 2026
Ra Capital Management, L.P. · New
Change +319K Date Q1 2026
Ra Capital Management, L.P. New· Q1 2026 +319K Q1 2026
Arrowstreet Capital, Limited Partnership · Reduced
Change −305K Date Q1 2026
Arrowstreet Capital, Limited Partnership Reduced· Q1 2026 −305K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 296

Famous investor activity in Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals, Inc. (MIRM) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Peetz Christopher · Director 4 operations −$2.4M
Price $121.65–$124.79 Qty −20K Owned 194K ΔOwn −9.3% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Peetz Christopher Director 4 operations $121.65–$124.79 −20K −$2.4M 194K −9.3% Jul 6, 2026 Jul 8, 2026
Peetz Christopher · Director 2 operations 0
Price $2.94 Owned 108K Trade date Jul 6, 2026 Filed date Jul 8, 2026
Peetz Christopher Director 2 operations $2.94 0 108K Jul 6, 2026 Jul 8, 2026
Bjerkholt Eric · Officer 4 operations −$611K
Price $121.67–$124.94 Qty −5K Owned 42K ΔOwn −10.6% Trade date Jul 6, 2026 Filed date Jul 8, 2026
Bjerkholt Eric Officer 4 operations $121.67–$124.94 −5K −$611K 42K −10.6% Jul 6, 2026 Jul 8, 2026
Howe Jolanda · Officer Sell −$327K
Price $120.00 Qty −3K Owned 3K ΔOwn −46.6% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Howe Jolanda Officer Sell $120.00 −3K −$327K 3K −46.6% Jul 1, 2026 Jul 2, 2026
Howe Jolanda · Officer Sell −$264K
Price $101.95 Qty −3K Owned 6K Trade date Jun 17, 2026 Filed date Jun 18, 2026
Howe Jolanda Officer Sell $101.95 −3K −$264K 6K Jun 17, 2026 Jun 18, 2026
Walbert Timothy P. · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Walbert Timothy P. Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Cardon Lon · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Cardon Lon Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Ramasastry Saira · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Ramasastry Saira Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Fairey William · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Fairey William Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Brege Laura · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Brege Laura Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Heron Patrick J. · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Heron Patrick J. Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Fischer Laurent · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Fischer Laurent Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Grey Michael G. · Director 2 operations 6K
Owned 2K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Grey Michael G. Director 2 operations 6K 2K Jun 15, 2026 Jun 17, 2026
Bjerkholt Eric · CFO 2 operations 0
Price $26.49 Owned 27K Trade date Jun 9, 2026 Filed date Jun 9, 2026
Bjerkholt Eric CFO 2 operations $26.49 0 27K Jun 9, 2026 Jun 9, 2026
Bjerkholt Eric · CFO 3 operations −$469K
Price $92.84–$95.12 Qty −5K Owned 45K Trade date Jun 8, 2026 Filed date Jun 9, 2026
Bjerkholt Eric CFO 3 operations $92.84–$95.12 −5K −$469K 45K Jun 8, 2026 Jun 9, 2026
15 of 101
15 of 101 Sign in to continue to older insider transactions.

Mirum Pharmaceuticals, Inc. (MIRM) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Janus Henderson Group PLC 4.5M
% of shares outstanding 9.4% Filing date Nov 14, 2024
Janus Henderson Group PLC 4.5M 9.4% Nov 14, 2024
Frazier Life Sciences Ix, L.P. 3.6M
% of shares outstanding 7.7% Filing date Sep 5, 2023
Frazier Life Sciences Ix, L.P. 3.6M 7.7% Sep 5, 2023
Eventide Asset Management, LLC 3.4M
% of shares outstanding 7.2% Filing date Nov 14, 2024
Eventide Asset Management, LLC 3.4M 7.2% Nov 14, 2024
Blackrock, Inc. 3.4M
% of shares outstanding 7.1% Filing date Nov 12, 2024
Blackrock, Inc. 3.4M 7.1% Nov 12, 2024
New Enterprise Associates 16, L.P. 2.2M
% of shares outstanding 5.8% Filing date Jun 23, 2023
New Enterprise Associates 16, L.P. 2.2M 5.8% Jun 23, 2023
Blackrock, Inc. 3.5M
% of shares outstanding 5.7% Filing date Apr 27, 2026
Blackrock, Inc. 3.5M 5.7% Apr 27, 2026
BlackRock Inc. 2.5M
% of shares outstanding 5.4% Filing date Jan 31, 2024
BlackRock Inc. 2.5M 5.4% Jan 31, 2024
Vanguard Group Inc 2.5M
% of shares outstanding 5.3% Filing date Feb 13, 2024
Vanguard Group Inc 2.5M 5.3% Feb 13, 2024
8 of 12

Mirum Pharmaceuticals, Inc. (MIRM) ownership FAQ

Who owns MIRM?

296 reporting institutions disclosed MIRM position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.